Results 251 to 260 of about 124,112 (267)

People also looked at

Frontiers in Medicine, 2021
Armando Magrelli, Segundo Mariz, Kristina Larsson   +2 more
exaly  

Drug repositioning for orphan diseases.

Briefings in Bioinformatics, 2011
Anil G. Jegga, Minlu Zhang
exaly  

The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?

Health Policy, 2010
Youwen Zhou
exaly  

Orphan Drugs and Their Impact on Pharmaceutical Development

Trends in Pharmacological Sciences, 2018
Helgi B Schiöth, Misty M Attwood, Mathias Rask-Andersen   +2 more
exaly  

The availability and affordability of orphan drugs for rare diseases in China

Orphanet Journal of Rare Diseases, 2016
Hanjun Sun, Yingxiao Wang, Si Jin
exaly  

Affordable orphan drugs: a role for not-for-profit organizations

British Journal of Clinical Pharmacology, 2017
Dyfrig A. Hughes
exaly  

Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors

Trends in Neurosciences, 2001
Rainer K Reinscheid, Olivier Civelli, Hans-Peter Nothacker   +2 more
exaly  

Patient Accessibility and Budget Impact of Orphan Drugs in South Korea: Long-Term and Real-World Data Analysis (2007–2019)

International Journal of Environmental Research and Public Health, 2020
Jong Hyuk Lee
exaly  

The Identification of Ligands at Orphan G-Protein Coupled Receptors

Annual Review of Pharmacology and Toxicology, 2004
Steven Jupe, Stephen Rees, Alan Wise
exaly  

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Nature Reviews Drug Discovery, 2010
M Miles Braun
exaly